Category: Pharmaceuticals - Page 3

By Barrie av / Jan, 3 2026

Aspirin Therapy for Heart Disease Prevention: Who Should Take It in 2026?

Aspirin is no longer recommended for most people to prevent first heart attacks. Learn who still might benefit from daily low-dose aspirin in 2026 based on updated guidelines, bleeding risks, and individual health factors.

By Barrie av / Jan, 1 2026

Pregnancy and Lactation Labeling Rule (PLLR): How to Read FDA Drug Safety Info

The FDA's Pregnancy and Lactation Labeling Rule (PLLR) replaced outdated letter categories with detailed, evidence-based safety info for pregnant and breastfeeding women. Learn how to read the new labels and make informed decisions.

By Barrie av / Dec, 31 2025

Fasted vs Fed State Testing: Why Both Conditions Matter for Health and Drugs

Fasted and fed state testing reveal how food affects drug absorption and exercise performance. Understanding both conditions ensures safer medications and smarter training strategies.

By Barrie av / Dec, 29 2025

Stability Testing Requirements: Temperature and Time Conditions for Pharmaceutical Products

Stability testing ensures pharmaceutical products remain safe and effective over time. This article details the mandatory temperature and time conditions under ICH Q1A(R2), including long-term, accelerated, and refrigerated protocols used globally.

By Barrie av / Dec, 28 2025

How Multiple Generic Drug Manufacturers Drive Down Prices

Multiple generic manufacturers drive down drug prices through competition, with studies showing up to 70% price drops when four or more makers enter the market. Learn how this works-and why fewer makers can lead to dangerous price spikes.

By Barrie av / Dec, 26 2025

How to Protect Your Privacy When Disposing of Medications

Learn how to safely dispose of old medications without risking your privacy. Follow simple steps to protect your health info from identity thieves and avoid environmental harm.

By Barrie av / Dec, 25 2025

Economic Impact of Patent Expiration: When Drug Prices Drop

When pharmaceutical patents expire, drug prices can drop by up to 80% as generics enter the market. This economic shift saves billions-but patent thickets and rebate deals often delay real savings for patients.

By Barrie av / Dec, 22 2025

Parkinson’s Disease: Understanding Tremor, Stiffness, and How Dopamine Replacement Works

Parkinson’s disease causes tremor, stiffness, and slowness due to dopamine loss in the brain. Levodopa is the main treatment, but long-term use brings side effects. Learn how dopamine replacement works, why timing matters, and what alternatives exist.

By Barrie av / Dec, 20 2025

Cystic Fibrosis: Genetic Respiratory Disease and How New Therapies Are Changing Outcomes

Cystic fibrosis is a genetic respiratory disease that thickens mucus, damaging lungs and organs. New CFTR modulator therapies now extend life expectancy to over 50 years, but access and cost remain major barriers.

By Barrie av / Dec, 18 2025

Drug Safety Signals and Clinical Trials: How Hidden Risks Emerge After Approval

Drug safety signals reveal hidden risks that clinical trials miss. Learn how real-world data, statistical tools, and regulatory systems detect adverse reactions after approval-and why patient reports matter.